vom 14.10.2020

Exercise against cancer: Online charity event in support of the NCT Heidelberg starts October 16

Due to the COVID19-pandemic this year's charity ragatta "Rudern gegen Krebs" ("Rowing against cancer") had to be cancelled. However, the organizer, the foundation "Leben mit Krebs" ("Living with Cancer") did not want to cancel the event completely. Therefore, the foundation as well as the National Center for Tumor Diseases Heidelberg and the Else Kröner-Fresenius-foundation appeal everyone to exercise from October 16 to November 15 2020, no matter if by bike, in a rowboat, in the swimming pool or by foot. Everyone can participate and track his or her own physical activity over the course of four weeks via the app "Beweg Dich gegen Krebs" ("Exercise against cancer"). The individual engagement of exercise can be transformed into a donation for sports and exercise projects at NCT Heidelberg later on. Registration and participation via the app is free of charge.

The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), the Heidelberg University Hospital (UKHD) and the German Cancer Aid (DKH).

The on-going spread of the corona virus SARS CoV-2 put an end to many events this year. "It was with a heavy heart that we had to cancel the ragatta we had planned on September 12. Yet we knew that the topic of exercise could not just be dropped for cancer patients. Especially in this kind of situation, it is our concern as a foundation to make sure that the supply of aligned sports programs is provided for oncological patients. This motivated us to strike out in new ways and start an unusual online charity event this year", says Klaus Schott, chairman of the board of the foundation "Leben mit Krebs". The foundation aims to establish exercise programs in the supply for oncological patients.

With the charity campaign "Beweg Dich gegen Krebs", organizers encourage everyone who is interested to exercise over the course of four weeks. Everything is possible - from biking to fitness, swimming or rowing. Thereby everyone contributes to his or her own health. If you want to do something beyond that, you can support the exercise programs for oncological patients at NCT Heidelberg with a donation. Furthermore, sponsors and supporters can do a lot of good for the charity event. The organizers are thankful for every support. The main sponsor of the charity event is SNP Schneider-Neureither & Partner SE.

In order to take part, participants can download a free app to their mobile devices here: beweg-dich-gegen-krebs.de. The campaign begins on Friday, October 16: " During the time of the campaign, everyone tracks their physical engagement via the app, on your own or in a team of four persons", explains Joachim Wiskemann, sports scientist and Head of the working group "Exercise oncology" at NCT Heidelberg and UKHD. With the hashtag #bewegdichgegenkrebs, personal experiences and successes can be shared during the time of the campaign on Facebook and Instagram.

Furthermore, the most active teams and single participants can look forward to attractive prices as goes for the most generous donors. The revenue from team and single donations as well as those of sponsors and supporters benefit the patient program „Bewegung und Krebs“ at NCT Heidelberg. " Experience from everyday care shows that the demand for qualified exercise programs for oncological patients is high. Donation revenues help to keep our exercise program going and expand it", says Dirk Jäger, Managing Director at NCT Heidelberg and Medical Director of Medical Oncology at UKHD. "Because we know from scientific research that aligned sports programs can alleviate side effects of tumor diseases and therapies thereof. This means an improvement of treatment results and a higher life quality for patients."


Fact overview:

Date: Friday October 16 until November 15 2020

Download app: https://beweg-dich-gegen-krebs.de

GooglePlay: https://play.google.com/stor/apps/details?id=com.bewegdichgegenkrebsapp
AppStore: https://apps.apple.com/us/app/id1530742375

Registration: via the app „Beweg Dich gegen Krebs“

Costs: Free of charge. Donations in support auf the foundation are requested. All revenues go to the charity patient program „Bewegung und Krebs“ at NCT Heidelberg.

Sports: Biking, Fitness, Running, Rowing, Swimming, Walking

Organizer: Foundation "Leben mit Krebs" ("Living with Cancer")

Become a sponsor: Sponsors, companies, institutions and associations are invited to offer campaign days, health days or challenges durng the campaign. You can get support for the organisation here: info@stiftung-leben-mit-krebs.de; Contact: joachim.wiskemann@nct-heidelberg.de


Stiftung Leben mit Krebs
Mainzer Straße 48
55252 Mainz-Kastel
Telefon: +49 61 34 / 753 81 38


Images for press release are available free of charge on the Internet at


Legend: From rowing to fitness exercises: Every participant can choose their favourite sport from the app "Beweg Dich gegen Krebs"


Legend: Physical activity has positive effects on body and mind during and after cancer therapy. That is where the NCT's exercising program comes in.

Copyright: NCT Heidelberg

Terms of use for image material for press releases
The use is free of charge. The NCT Heidelberg permits one-time use in connection with reporting on the topic of the press release. Please indicate as picture credits: "Copyright NCT Heidelberg". The images may only be passed on to third parties after prior consultation with the NCT press office (Tel. 06221 56 5930, e-mail friederike.fellenberg@nct-heidelberg.de). Use for commercial purposes is prohibited.

Press contact:

Dr. Friederike Fellenberg
National Center for Tumor Diseases Heidelberg (NCT)
Press and Public Relations
Im Neuenheimer Feld 460
69120 Heidelberg
Tel.: +49 6221 56-5930
Fax: +49 6221 56-5350
Email: friederike.fellenberg@nct-heidelberg.de

Dr. Sibylle Kohlstädt
German Cancer Research Center (DKFZ)
Communications and Marketing
Im Neuenheimer Feld 280
69120 Heidelberg
Tel.: +49 6221 42-2843
Fax: +49 6221 42-2968
Email: s.kohlstaedt@dkfz.de

Doris Rübsam-Brodkorb
Heidelberg University Hospital and Medical Faculty of the University of Heidelberg
Press and Public Relations
Im Neuenheimer Feld 672
69120 Heidelberg
Tel.: +49 6221 56-5052
Fax: +49 6221 56-4544
Email: doris.ruebsam-brodkorb@med.uni-heidelberg.de

National Center for Tumor Diseases Heidelberg (NCT)
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center, Heidelberg University Hospital (UKHD) and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. This is true for diagnosis and treatment, follow-up care or prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here, the patients benefit from an individual treatment plan prepared in interdisciplinary expert rounds, so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, the NCT Heidelberg has maintained a partner site in Dresden. The Hopp Children's Cancer Center (KiTZ) was established in Heidelberg in 2017. The pediatric oncologists at KiTZ work together in parallel structures with the NCT Heidelberg.

German Cancer Research Center (DKFZ)
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) with its more than 3,000 employees is the largest biomedical research institution in Germany. More than 1,300 scientists at the DKFZ investigate how cancer develops, identify cancer risk factors and search for new strategies to prevent people from developing cancer. They are developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to all questions on cancer.
Jointly with partners from the university hospitals, the DKFZ operates the National Center for Tumor Diseases (NCT) in Heidelberg and Dresden, and the Hopp Children's Tumour Center KiTZ in Heidelberg. In the German Consortium for Translational Cancer Research (DKTK), one of the six German Centers for Health Research, the DKFZ maintains translational centers at seven university partner locations. NCT and DKTK sites combine excellent university medicine with the high-profile research of the DKFZ. They contribute to the endeavor of transferring promising approaches from cancer research to the clinic and thus improving the chances of cancer patients.
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

Heidelberg University Hospital (UKHD)
Heidelberg University Hospital (UKHD) is one of the most important medical centers in Germany; Heidelberg University's Medical Faculty is one of Europe's most prestigious biomedical research facilities. Their shared objective is the development of innovative diagnostics and treatments and their prompt implementation for the benefit of the patient. The hospital and faculty employ approximately 13,000 individuals and are involved in training and qualification. Every year approximately 65,000 patients are treated as inpatients and 56,000 as day patients in more than 50 specialized clinical departments with around 2,000 beds, with more than 1 million patients being treated as outpatients. Together with the German Cancer Research Center and German Cancer Aid, the Heidelberg University Hospital established The National Center for Tumor Diseases (NCT) Heidelberg as the leading oncology center of excellence in Germany. The Heidelberg Curriculum Medicinale (HeiCuMed) is at the forefront of medical training in Germany. At present 3,700 aspiring physicians and doctors are studying in Heidelberg.